DKCM
WVE icon

Davidson Kempner Capital Management’s Wave Life Sciences WVE Stock Holding History

Davidson Kempner Capital Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-970,000
Closed -$6.78M – 410
2022
Q4 		$6.78M Buy
+970,000
New +$4.47M 0.13% 143

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Davidson Kempner Capital Management's WVE Position: Q1 2023 in Review

Davidson Kempner Capital Management sold out of Wave Life Sciences (WVE) in Q1 2023, closing a stake of 970,000 shares — an estimated $6.78M sold.

Davidson Kempner Capital Management first reported a position in WVE in Q4 2022 and held it in 1 quarter. The position peaked at $6.78M in Q4 2022. 72 funds tracked by Wall St. Rank hold WVE as of Q1 2023.

  • Davidson Kempner Capital Management reported no remaining Wave Life Sciences position as of Q1 2023 after selling out during the quarter.
  • Davidson Kempner Capital Management sold 970,000 Wave Life Sciences shares in Q1 2023, an estimated $6.78M.
  • Davidson Kempner Capital Management first reported a position in Wave Life Sciences in Q4 2022 and held it in 1 quarter.
  • Davidson Kempner Capital Management's Wave Life Sciences position peaked at $6.78M in Q4 2022.
  • 72 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2023.

Based on Davidson Kempner Capital Management's 13F filing for Q1 2023, filed 15 May 2023.